2023 - Research.com Best Scientist Award
2022 - Research.com Best Scientist Award
Jubilee Prize, Swedish Medical Society
Hans-Olov Adami focuses on Internal medicine, Cancer, Risk factor, Epidemiology and Gynecology. Hans-Olov Adami interconnects Gastroenterology, Surgery and Oncology in the investigation of issues within Internal medicine. His work carried out in the field of Cancer brings together such families of science as Immunology and Pathology.
The study incorporates disciplines such as Endocrinology, Absolute risk reduction, Case-control study and Environmental health in addition to Risk factor. Hans-Olov Adami works mostly in the field of Epidemiology, limiting it down to concerns involving Incidence and, occasionally, Demography, Mass screening, Mortality rate and Colorectal cancer. The Gynecology study combines topics in areas such as Body mass index, Cervical cancer, Obstetrics, Breast cancer and Cohort.
Hans-Olov Adami mostly deals with Internal medicine, Cancer, Epidemiology, Breast cancer and Oncology. His work deals with themes such as Endocrinology and Surgery, which intersect with Internal medicine. His Cancer research incorporates themes from Gastroenterology and Pathology.
His Epidemiology study incorporates themes from Incidence, Environmental health, Demography, Confidence interval and Public health. His Breast cancer study which covers Gynecology that intersects with Obstetrics, Cervical cancer, Endometrial cancer, Confounding and Menopause. His study in Risk factor is interdisciplinary in nature, drawing from both Odds ratio, Absolute risk reduction, Case-control study, Immunology and Disease.
His primary scientific interests are in Internal medicine, Oncology, Cancer, Cohort and Epidemiology. His study looks at the relationship between Oncology and fields such as Disease, as well as how they intersect with chemical problems. The concepts of his Cancer study are interwoven with issues in Twin study, Heritability, Incidence, Gastroenterology and Lower risk.
His work in Incidence addresses issues such as Relative risk, which are connected to fields such as Gynecology. The various areas that Hans-Olov Adami examines in his Cohort study include Demography, Retrospective cohort study and Ovarian cancer. His work in Epidemiology covers topics such as Public health which are related to areas like Family medicine.
Internal medicine, Oncology, Cancer, Prospective cohort study and Body mass index are his primary areas of study. His Surgery research extends to the thematically linked field of Internal medicine. His Oncology research is multidisciplinary, incorporating elements of Survival rate and Breast cancer.
His Breast cancer study combines topics in areas such as Young adult, Family history, Obstetrics and Risk factor. His research in Cancer intersects with topics in Twin study, Lower risk, Lung cancer and Gastroenterology. Hans-Olov Adami has included themes like Epidemiology and Retrospective cohort study in his Prospective cohort study study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
E. E. Calle;C. W. Heath;R. J. Coates;J. M. Liff.
The Lancet (1997)
Ulcerative colitis and colorectal cancer. A population-based study.
Anders Ekbom;Charles Helmick;Matthew Zack;Hans-Olov Adami.
The New England Journal of Medicine (1990)
Radical prostatectomy versus watchful waiting in early prostate cancer.
Anna Bill-Axelson;Anna Bill-Axelson;Lars Holmberg;Mirja Ruutu;Hans Garmo.
The New England Journal of Medicine (2005)
Breast cancer and hormonal contraceptives : collaborative reanalysis of individual data on 53.297 women with breast cancer and 100.239 women without breast cancer from 54 epidemiological studies
E. E. Calle;C. W. Heath;H. L. Miracle-McMahill;R. J. Coates.
The Lancet (1996)
Epidemiology and etiology of Parkinson’s disease: a review of the evidence
Karin Wirdefeldt;Hans-Olov Adami;Hans-Olov Adami;Philip Cole;Dimitrios Trichopoulos.
European Journal of Epidemiology (2011)
The enigmatic epidemiology of nasopharyngeal carcinoma.
Ellen T. Chang;Hans-Olov Adami.
Cancer Epidemiology, Biomarkers & Prevention (2006)
Leisure Time Physical Activity and Mortality: A Detailed Pooled Analysis of the Dose-Response Relationship
Hannah Arem;Steven C. Moore;Alpa Patel;Patricia Hartge.
JAMA Internal Medicine (2015)
Pooled Analysis of Prospective Cohort Studies on Height, Weight, and Breast Cancer Risk
Piet A. Van Den Brandt;Donna Spiegelman;Shiaw Shyuan Yaun;Hans Olov Adami.
American Journal of Epidemiology (2000)
Overweight as an avoidable cause of cancer in Europe
Anna Bergström;Paola Pisani;Vanessa Tenet;Alicja Wolk.
International Journal of Cancer (2001)
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer
Lars Holmberg;Anna Bill-Axelson;Fred Helgesen;Jaakko O. Salo.
The New England Journal of Medicine (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: